1180548

Biohaven Pharmaceuticals, Inc — FEI 3010802167

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)